Seres Therapeutics Marella Thorell Resigns As Evp And CFO Effective November 15, 2026 - SEC Filing
Oct 26 (Reuters) - Seres Therapeutics, Inc. MCRB.O:
SERES THERAPEUTICS: MARELLA THORELL RESIGNS AS EVP AND CFO EFFECTIVE NOVEMBER 15, 2026 - SEC FILING
SERES THERAPEUTICS - MARELLA THORELL EXPECTED TO PROVIDE ADVISORY SERVICES FOLLOWING NOVEMBER 15, 2026 - SEC FILING
Source text: [ID:n0001193125-26-432004]
Further company coverage: MCRB.O